130 related articles for article (PubMed ID: 16981902)
1. Chemotherapy for older patients with prostate cancer.
Anderson J; Van Poppel H; Bellmunt J; Miller K; Droz JP; Fitzpatrick JM
BJU Int; 2007 Feb; 99(2):269-73. PubMed ID: 16981902
[No Abstract] [Full Text] [Related]
2. Management of prostate cancer in the older man.
Mohile SG; Lachs M; Dale W
Semin Oncol; 2008 Dec; 35(6):597-617. PubMed ID: 19027464
[TBL] [Abstract][Full Text] [Related]
3. Elderly cancer patients: our future?
Perrone F; Di Maio M
Clin Ter; 2002; 153(3):159-60. PubMed ID: 12161975
[No Abstract] [Full Text] [Related]
4. Medical therapy of solid tumors in the elderly: an update.
Balducci L
Rays; 1997; 22(1 Suppl):20-3. PubMed ID: 9250009
[TBL] [Abstract][Full Text] [Related]
5. [Surveillance of prostate adenoma patients administering selective alpha-1a-adrenoblocker].
Zhukov VF; Vasil'chenko MI; Proletarskiĭ AV
Voen Med Zh; 2004 Apr; 325(4):44-7. PubMed ID: 15188540
[No Abstract] [Full Text] [Related]
6. Prostate cancer chemotherapy in the era of targeted therapy.
Michael A; Syrigos K; Pandha H
Prostate Cancer Prostatic Dis; 2009; 12(1):13-6. PubMed ID: 18521103
[TBL] [Abstract][Full Text] [Related]
7. Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer.
Nakabayashi M; Ling J; Xie W; Regan MM; Oh WK
Cancer J; 2007; 13(2):125-9. PubMed ID: 17476141
[TBL] [Abstract][Full Text] [Related]
8. The role of systemic cytotoxic therapy for prostate cancer.
Chang SS; Kibel AS
BJU Int; 2009 Jan; 103(1):8-17. PubMed ID: 19040524
[TBL] [Abstract][Full Text] [Related]
9. The case for early chemotherapy for the treatment of metastatic disease.
Lucas A; Petrylak DP
J Urol; 2006 Dec; 176(6 Pt 2):S72-5. PubMed ID: 17084173
[TBL] [Abstract][Full Text] [Related]
10. Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15.
Huang CY; Beer TM; Higano CS; True LD; Vessella R; Lange PH; Garzotto M; Nelson PS
Clin Cancer Res; 2007 Oct; 13(19):5825-33. PubMed ID: 17908975
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for prostate cancer in senior adults: are we treating the elderly or the frail?
Bellmunt J
Eur Urol; 2009 Jun; 55(6):1310-2. PubMed ID: 18778888
[No Abstract] [Full Text] [Related]
12. [Antiblastic chemotherapy in the treatment of cancer of the prostate].
Pavone-Macaluso M; Caramia G; Vecchioni M
J Urol Nephrol (Paris); 1972; 78(7):621-34. PubMed ID: 4675962
[No Abstract] [Full Text] [Related]
13. A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer.
Ryan CJ; Harzstark AH; Rosenberg J; Lin A; Claros C; Goldfine ID; Kerner JF; Small EJ; Youngren JF
BJU Int; 2008 Feb; 101(4):436-9. PubMed ID: 18234062
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for advanced prostate cancer: 25 years later.
Logothetis CJ; Millikan R
J Clin Oncol; 2008 May; 26(15):2423-4. PubMed ID: 18487561
[No Abstract] [Full Text] [Related]
15. Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
Korfage IJ; de Koning HJ; Habbema JD; Schröder FH; Essink-Bot ML
BJU Int; 2007 Apr; 99(4):801-6. PubMed ID: 17233804
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with prostate cancer receiving zoledronic acid or pamidronate for prevention of skeletal-related events.
Sherer JT; Adamus AT
Pharmacotherapy; 2007 Feb; 27(2):207-17. PubMed ID: 17253911
[TBL] [Abstract][Full Text] [Related]
17. Body image perceptions in men with prostate cancer.
Harrington JM; Jones EG; Badger T
Oncol Nurs Forum; 2009 Mar; 36(2):167-72. PubMed ID: 19273405
[TBL] [Abstract][Full Text] [Related]
18. Systemic therapies for non-metastatic prostate cancer: review of the literature.
Jereczek-Fossa BA; Curigliano G; Orecchia R
Onkologie; 2009 Jun; 32(6):359-63. PubMed ID: 19521126
[TBL] [Abstract][Full Text] [Related]
19. Primary endobronchial non-Hodgkin lymphoma in an 80-year-old patient with prostate cancer.
Hardavella G; Thalassinos N; Anastasiou N
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):739-40. PubMed ID: 19589791
[TBL] [Abstract][Full Text] [Related]
20. Prostate specific antigen (PSA) may be a poor marker for progression of prostate cancer after treatment with a combination of chemo-hormonal therapies.
Sartor O
J La State Med Soc; 2008; 160(2):99-100. PubMed ID: 18681353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
